Genmab A/S (GMAB) Earnings Date, Estimates & Call Transcripts $20.66 +0.16 (+0.78%) As of 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Genmab A/S Earnings Summary Genmab A/S released Q1 2025 earnings on May 8, 2025, reporting an EPS of $0.31, which beat the consensus estimate of $0.23 by $0.08. Quarterly revenue was reported to be $715 million, below analysts' expectations of $5.17 billion. With a trailing EPS of $1.76 and a P/E Ratio of 14.75, Genmab A/S's earnings are expected to grow 22.76% next year, from $1.45 to $1.78 per share. Upcoming Q2 Earnings DateAug. 14Before Market OpensEstimatedConsensus EPS (May. 8) $0.23 Actual EPS (May. 8) $0.31 Beat By $0.08 Actual Revenue (May. 8) $715.00MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Interim Report Press Release (6-K) Slide DeckGMAB Upcoming EarningsGenmab A/S's next earnings date is estimated for Thursday, August 14, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get Genmab A/S Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Genmab A/S and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataGMAB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GMAB Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Genmab A/S Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue GuidanceQ1 20252$0.17$0.21$0.19Q2 20251$0.41$0.41$0.41Q3 20253$0.42$0.46$0.44Q4 20253$0.43$0.62$0.50 FY 2025 9 $1.43 $1.70 $1.53 Q1 20262$0.33$0.37$0.35Q2 20262$0.57$0.60$0.59Q3 20262$0.62$0.65$0.64Q4 20262$0.67$0.72$0.70 Genmab A/S Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/14/2025(Estimated)--------5/8/2025Q1 2025$0.23$0.31+$0.08$0.31$5.17B$715.00M2/12/2025Q4 2024$0.28$0.57+$0.29$0.85$884.02M-11/6/2024Q3 2024$0.32$0.29 -$0.03$0.29$838.20M$816.10M8/8/2024Q2 2024$0.29$0.22 -$0.07$0.13$734.60M$779.50M5/2/2024Q1 2024$0.16$0.16-$0.03$594.23M$603.30M2/14/2024Q4 2023$0.34$0.36+$0.02$0.58$678.14M$675.29M11/7/2023Q3 2023$0.34$0.47+$0.13$0.47$657.79M$692.80M8/3/2023Q2 2023$0.31$0.30 -$0.01$0.30$618.77M$613.43M Genmab A/S Earnings - Frequently Asked Questions When is Genmab A/S's earnings date? Genmab A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 14th, 2025 based off last year's report dates. Learn more on GMAB's earnings history. What guidance has Genmab A/S issued on next quarter's earnings? Genmab A/S updated its FY 2025 earnings guidance on Thursday, May, 8th. The company issued revenue guidance of $3.3 billion-$3.7 billion, compared to the consensus revenue estimate of $3.7 billion. Did Genmab A/S beat their earnings estimates last quarter? In the previous quarter, Genmab A/S (NASDAQ:GMAB) reported $0.31 earnings per share (EPS) to beat the analysts' consensus estimate of $0.23 by $0.08. Learn more on analysts' earnings estimate vs. GMAB's actual earnings. How can I listen to Genmab A/S's earnings conference call? The conference call for Genmab A/S's latest earnings report can be listened to online. Listen to Conference Call How can I read Genmab A/S's conference call transcript? The conference call transcript for Genmab A/S's latest earnings report can be read online. Read Transcript How much revenue does Genmab A/S generate each year? Genmab A/S (NASDAQ:GMAB) has a recorded annual revenue of $3.12 billion. How much profit does Genmab A/S generate each year? Genmab A/S (NASDAQ:GMAB) has a recorded net income of $1.14 billion. GMAB has generated $1.76 earnings per share over the last four quarters. What is Genmab A/S's price-to-earnings ratio? Genmab A/S (NASDAQ:GMAB) has a trailing price-to-earnings ratio of 11.68 and a forward price-to-earnings ratio of 14.17. The price/earnings-to-growth ratio is 6.76. What is Genmab A/S's EPS forecast for next year? Genmab A/S's earnings are expected to grow from $1.45 per share to $1.78 per share in the next year, which is a 22.76% increase. More Earnings Resources from MarketBeat Related Companies TAK Earnings Date ARGX Earnings Date ONC Earnings Date BNTX Earnings Date TEVA Earnings Date SMMT Earnings Date ITCI Earnings Date RDY Earnings Date ASND Earnings Date VTRS Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Smith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record Highs This page (NASDAQ:GMAB) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNvidia’s Huang: AI is going to need 100x more power12Nvidia CEO Jensen Huang didn't mince words. After Nvidia's latest earnings call, Huang said AI now requires...Weiss Ratings | SponsoredGold Shock (insane new prediction)World Gold Council reports: "No sign" of this catalyst slowing A whopping 73% of Americans report they're "...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genmab A/S Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Genmab A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
